Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stabilityAnkit K. Dutta, Andrew C.W. Zannettino|Leukemia|2018Cited by 148
Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cellsSally K. Martin, Andrew C.W. Zannettino|Haematologica|2009Cited by 94